Polynovo's (ASX:PNV) patchy global sales counter strong US growth

Latest Company News - Finance News Network

English - January 11, 2022 01:00 - 1000 KB
Business News News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Ingham's (ASX:ING) sales hit by Omicron wave

Next Episode: PointsBet (ASX:PBH) partners up with NHL Alumni in USA

11 Jan 2022 - Global sales in biotech giant PolyNovo (ASX:PNV) have surged 45% to $16.3 million from a year ago, led by encouraging sales in the US while global sales were described as "patchy".